134 related articles for article (PubMed ID: 8856147)
1. In vivo pharmacological profile of novel, potent, stable BK antagonists at B1 and B2 receptors.
Hanson WL; McCullough RG; Selig WM; Wieczorek M; Ross S; Whalley ET; Stewart JM; Gera L
Immunopharmacology; 1996 Jun; 33(1-3):191-3. PubMed ID: 8856147
[No Abstract] [Full Text] [Related]
2. Comparative profile of novel potent bradykinin antagonists at human B1 and B2 receptors.
Burkard M; Zuzack JS; Jones S; Francis M; Whalley ET; Stewart JM; Gera L
Immunopharmacology; 1996 Jun; 33(1-3):186-90. PubMed ID: 8856146
[TBL] [Abstract][Full Text] [Related]
3. A new generation of bradykinin antagonists.
Stewart JM; Gera L; Hanson W; Zuzack JS; Burkard M; McCullough R; Whalley ET
Immunopharmacology; 1996 Jun; 33(1-3):51-60. PubMed ID: 8856115
[TBL] [Abstract][Full Text] [Related]
4. A new class of potent bradykinin antagonist dimers.
Gera L; Stewart JM; Whalley E; Burkard M; Zuzack JS
Immunopharmacology; 1996 Jun; 33(1-3):178-82. PubMed ID: 8856144
[No Abstract] [Full Text] [Related]
5. A new class of bradykinin antagonists containing indanylglycine.
Gera L; Stewart JM
Immunopharmacology; 1996 Jun; 33(1-3):174-7. PubMed ID: 8856143
[No Abstract] [Full Text] [Related]
6. Potent, long-acting bradykinin antagonists for a wide range of applications.
Stewart JM; Gera L; Chan DC; Whalley ET; Hanson WL; Zuzack JS
Can J Physiol Pharmacol; 1997 Jun; 75(6):719-24. PubMed ID: 9276154
[TBL] [Abstract][Full Text] [Related]
7. New bradykinin antagonists having very high potency at B1 receptors.
Gera L; Stewart JM; Whalley ET; Burkard M; Zuzack JS
Immunopharmacology; 1996 Jun; 33(1-3):183-5. PubMed ID: 8856145
[No Abstract] [Full Text] [Related]
8. Haemodynamic and cardiac effects of kinin B1 and B2 receptor stimulation in conscious instrumented dogs.
Bélichard P; Loillier B; Paquet JL; Luccarini JM; Pruneau D
Br J Pharmacol; 1996 Apr; 117(7):1565-71. PubMed ID: 8730755
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of bradykinin B2-receptors on endothelial cells induces relaxation and contraction in porcine basilar artery in vitro.
Miyamoto A; Ishiguro S; Nishio A
Br J Pharmacol; 1999 Sep; 128(1):241-7. PubMed ID: 10498858
[TBL] [Abstract][Full Text] [Related]
10. Antagonists for kinin B1 and B2 receptors in the mouse.
Nsa Allogho S; Gobeil F; Pheng LH; Nguyen-Le XK; Neugebauer W; Regoli D
Can J Physiol Pharmacol; 1997 Jun; 75(6):558-62. PubMed ID: 9276128
[TBL] [Abstract][Full Text] [Related]
11. Bradykinin B1 receptors in the rabbit urinary bladder: induction of responses, smooth muscle contraction, and phosphatidylinositol hydrolysis.
Butt SK; Dawson LG; Hall JM
Br J Pharmacol; 1995 Feb; 114(3):612-7. PubMed ID: 7735687
[TBL] [Abstract][Full Text] [Related]
12. Potent, long-acting, orally-active bradykinin antagonists for a wide range of applications.
Stewart JM; Gera L; Chan DC; Whalley ET; Hanson WL; Zuzack JS
Immunopharmacology; 1997 Jun; 36(2-3):167-72. PubMed ID: 9228542
[TBL] [Abstract][Full Text] [Related]
13. Bradykinin receptor antagonists containing N-substituted amino acids: in vitro and in vivo B(2) and B(1) receptor antagonist activity.
Goodfellow VS; Marathe MV; Kuhlman KG; Fitzpatrick TD; Cuadrado D; Hanson W; Zuzack JS; Ross SE; Wieczorek M; Burkard M; Whalley ET
J Med Chem; 1996 Mar; 39(7):1472-84. PubMed ID: 8691478
[TBL] [Abstract][Full Text] [Related]
14. Non-selectivity of new bradykinin antagonists for B1 receptors.
Rhaleb NE; Gobeil F; Regoli D
Life Sci; 1992; 51(11):PL125-9. PubMed ID: 1326066
[TBL] [Abstract][Full Text] [Related]
15. Two B1 and B2 bradykinin receptor antagonists fail to inhibit the Ca2+ response elicited by bradykinin in human skin fibroblasts.
Cassano G; Susca F; Lippe C; Guanti G
Gen Pharmacol; 1999 Feb; 32(2):239-44. PubMed ID: 10188626
[TBL] [Abstract][Full Text] [Related]
16. Mediation by B1 and B2 receptors of vasodepressor responses to intravenously administered kinins in anaesthetized dogs.
Nakhostine N; Ribuot C; Lamontagne D; Nadeau R; Couture R
Br J Pharmacol; 1993 Sep; 110(1):71-6. PubMed ID: 8220916
[TBL] [Abstract][Full Text] [Related]
17. Receptors for kinins: from classical pharmacology to molecular biology.
Regoli D; Pheng LH; Allogho SN; Nguyen-Le XK; Gobeil F
Immunopharmacology; 1996 Jun; 33(1-3):116-22. PubMed ID: 8856128
[TBL] [Abstract][Full Text] [Related]
18. Bradykinin-induced vascular responses in dog isolated lingual artery.
Tsukada M; Chiba S
Clin Exp Pharmacol Physiol; 1999; 26(5-6):456-60. PubMed ID: 10386238
[TBL] [Abstract][Full Text] [Related]
19. Characterization of des-Arg9-bradykinin-induced contraction in guinea-pig gallbladder in vitro.
Cabrini DA; Calixto JB
Eur J Pharmacol; 1997 Jul; 331(1):31-8. PubMed ID: 9274927
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of a novel, orally active, nonpeptide bradykinin B2 receptor antagonist, FR167344.
Inamura N; Asano M; Hatori C; Sawai H; Hirosumi J; Fujiwara T; Kayakiri H; Satoh S; Abe Y; Inoue T; Sawada Y; Oku T; Nakahara K
Eur J Pharmacol; 1997 Aug; 333(1):79-86. PubMed ID: 9311664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
